Avalo Therapeutics, Inc.

NasdaqCM:AVTX Stock Report

Mkt Cap: US$37.7m

Avalo Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure

CEO

Garry Neil (68 yo)

0.58yr

Tenure

US$2,725,351

Compensation

Dr. Garry A. Neil, M.D., serves as Director of Celldex Therapeutics, Inc. since June 16, 2022. He has been President & Chief Executive Officer at Avalo Therapeutics, Inc. (formerly known as Cerecor Inc.) s...

CEO Compensation Analysis

How has Garry Neil's remuneration changed compared to Avalo Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$51m

Jun 30 2022n/an/a

-US$72m

Mar 31 2022n/an/a

-US$76m

Dec 31 2021n/an/a

-US$84m

Sep 30 2021n/an/a

-US$81m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$73m

Dec 31 2020US$3mUS$373k

-US$64m

Compensation vs Market: Insufficient data to establish whether Garry's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Garry's compensation with company performance.

Leadership Team

NamePositionTenureCompensationOwnership
Garry Neil
Chairman of the Board0.92yrUS$2.73m0.098%
$ 36.9k
Solomon Snyder
Founder and Chairman of Scientific Advisory Boardno datano datano data
Barbara Slusher
Founder and Member of Scientific Advisory Boardno datano datano data
Christopher Sullivan
Chief Financial Officer0.92yrno data0.0080%
$ 3.0k
Lisa Hegg
Senior Vice President of Program Management & Corporate Infrastructure3yrsno datano data
Maxim Jacobs
Vice President of Investor Relationsno datano datano data
Stephen Thomas
VP & Head of Discovery4.33yrsno datano data
Colleen Matkowski
Senior Vice President of Global Regulatory Affairs & Quality Assurance1yrno datano data
Dino Miano
Senior Vice President of CMC & Technical Operations0.92yrno datano data
Blake Paterson
Scientific Advisorno dataUS$1.09mno data

1.0yrs

Average Tenure

65yo

Average Age

Experienced Management: AVTX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Garry Neil
Chairman of the Board0.58yrUS$2.73m0.098%
$ 36.9k
Solomon Snyder
Founder and Chairman of Scientific Advisory Boardno datano datano data
Barbara Slusher
Founder and Member of Scientific Advisory Boardno datano datano data
Sol Barer
Special Advisor & Strategic Advisory Board1.58yrsUS$133.94kno data
Gilla Kaplan
Independent Director2.25yrsUS$153.98k0%
$ 0
Gunnar Magnus Severus Persson
Lead Independent Director10.42yrsUS$167.98k0%
$ 0
Ronald Borchardt
Member of Scientific Advisory Boardno datano datano data
Robert Lenox
Member of Scientific Advisory Boardno datano datano data
Anne Young
Member of Scientific Advisory Boardno datano datano data
Dennis Liotta
Member of Scientific Advisory Boardno datano datano data
June Almenoff
Independent Director1.17yrsUS$138.09k0%
$ 0
Mitchell Chan
Independent Director1.17yrsUS$111.30kno data

1.4yrs

Average Tenure

68yo

Average Age

Experienced Board: AVTX's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.